APA-referens

Cohen, S. B., Tanaka, Y., Mariette, X., Curtis, J. R., Lee, E. B., Nash, P., . . . Wollenhaupt, J. (2020). Long-term safety of tofacitinib up to 9.5 years: A comprehensive integrated analysis of the rheumatoid arthritis clinical development programme. RMD Open.

Chicago-stil citat

Cohen, Stanley B., et al. "Long-term Safety of Tofacitinib Up to 9.5 Years: A Comprehensive Integrated Analysis of the Rheumatoid Arthritis Clinical Development Programme." RMD Open 2020.

MLA-referens

Cohen, Stanley B., et al. "Long-term Safety of Tofacitinib Up to 9.5 Years: A Comprehensive Integrated Analysis of the Rheumatoid Arthritis Clinical Development Programme." RMD Open 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.